Vectura Group plc announced a key appointment to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space. Sharon Johnson has been appointed to the position of Executive Vice President for Delivery Management, a newly-created leadership role focussed on helping the company to transform into a successful CDMO. In her new role, Ms. Johnson will build an end-to-end approach to ensuring successful customer acquisition and programme management, as well as managing the regulatory affairs and medical affairs departments. She joins the Group on 10th February. Ms. Johnson has more than thirty years of experience in the pharmaceutical industry, and prior to joining Vectura has held a number of executive positions, most recently as Senior Vice President, Global Quality and Regulatory Affairs at Catalent, one of the world's leading CDMOs. Earlier in her career, she held the position of Vice President of Quality for GE Healthcare's Medical Diagnostic Division, and worked in roles of increasing responsibility for Baxter Healthcare and Sanofi Aventis. Ms. Johnson holds a postgraduate Diploma in Industrial Pharmaceutical Studies with Distinction from Brighton University and a BS Honours degree in Biological Sciences/Microbiology from North East Surrey College of Technology.